Clinical Trial Update: Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Progel Sealant to standard of care for patients undergoing decortication has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Progel Sealant

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Diseases, Mesothelioma | Phase 3 | Status: WITHDRAWN